← ORTHOPEDIATRICS CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($6.6m) ($8.9m) ($12.0m) ($13.7m) ($32.9m) ($16.3m) $1.3m ($21.0m) ($37.8m) ($39.6m)
Net Income (Loss) Available to Common Stockholders, Basic ($12.4m) ($23.5m) ($12.0m) ($13.7m) ($32.9m) — $1.2m ($21.0m) ($37.8m) ($39.6m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($6.6m) ($8.9m) ($12.0m) ($12.7m) ($32.9m) ($16.3m) $1.3m ($21.0m) ($37.8m) ($39.6m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest — — — — — ($16.3m) — — — —
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0 $0 — ($1.0m) $0 $0 — — — —
Depreciation, Depletion and Amortization $1.9m $2.4m $2.9m $4.7m $8.0m $10.7m $13.1m $17.4m $19.1m $21.1m
Depreciation $1.9m $2.2m $2.5m $3.7m $4.7m $6.1m $7.1m $10.2m $10.9m $12.0m
Amortization of Intangible Assets $35k $246k $378k $887k $3.2m $4.5m $6.0m $7.1m $7.8m $8.2m
Deferred Income Tax Expense (Benefit) — — — — — — — — ($4.7m) ($153k)
Share-based Payment Arrangement, Noncash Expense $1.3m $3.5m $3.2m $2.6m $6.2m $5.8m $6.7m $10.5m $13.5m $17.8m
Payment, Tax Withholding, Share-based Payment Arrangement $0 $990k $0 $0 — — — — — —
Share-based Payment Arrangement, Expense — — — — — — — — $13.5m $17.8m
Goodwill and Intangible Asset Impairment — — — — — — — $985k $1.8m $6.5m
Goodwill, Impairment Loss — — — — — — $0 $0 $0 $1.9m
Impairment of Intangible Assets, Finite-lived $0 $0 $0 $0 $0 $0 $0 $0 $0 $400k
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0 $0 $0 $0 $0 $3.6m $985k $1.8m $4.6m
Restructuring Costs and Asset Impairment Charges — — — — — — — — $3.7m —
Gain (Loss) on Disposition of Assets $0 $0 — ($210k) $0 $0 — — — —
Gain (Loss) on Extinguishment of Debt — — — — — — $0 $0 ($3.2m) $0
Income Tax Expense (Benefit) $0 $0 $0 $0 ($723k) ($1.1m) ($4.9m) ($338k) ($4.1m) $460k
Interest Expense Nonoperating — — — — — — — — $2.6m $6.0m
Other Nonoperating Income (Expense) $1.0m $30k ($217k) ($70k) $20k $1.1m ($1.8m) $2.3m ($1.1m) $6.0m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories — — — $9.8m $12.1m $5.0m $16.9m $26.3m $13.2m $8.5m
Increase (Decrease) in Accounts Payable $1.5m $2.0m ($1.5m) $2.4m $3.1m ($567k) ($209k) $1.5m ($4.3m) $8.2m
Proceeds from Stock Options Exercised $0 $0 $410k $1.1m $1.6m $137k $63k $21k $0 $0
General and Administrative Expense $11.6m $17.0m $20.9m $26.7m $38.3m $46.1m $59.4m $75.4m $102.8m $119.8m
Goodwill — — — $26.2m $70.5m $72.3m $86.8m $83.7m $93.8m $109.3m
Inventory Write-down $219k $344k $504k $604k $1.3m $1.1m $1.0m $995k $914k —
Nonoperating Income (Expense) ($445k) ($2.5m) ($2.5m) ($3.6m) ($6.9m) $636k $21.7m $5.4m ($6.9m) $50k
Operating Expenses $32.5m $40.9m $52.2m $63.7m $81.8m $91.4m $116.1m $138.0m $183.6m $211.9m
Realized Investment Gains (Losses) — — — — — — ($1.6m) ($1.4m) $119k $32k
Net Cash Provided by (Used in) Operating Activities ($1.1m) ($7.2m) ($15.6m) ($17.8m) ($18.5m) ($13.1m) ($21.8m) ($27.0m) ($27.0m) ($4.9m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $4.3m $5.2m $5.3m $11.8m $10.5m $8.1m $10.0m $16.9m $14.3m $11.1m
Payments to Acquire Businesses, Net of Cash Acquired — — — $49.8m $1.7m $0 $8.4m $0 $20.2m $0
Net Cash Provided by (Used in) Investing Activities ($4.8m) ($6.5m) ($6.0m) ($61.9m) ($69.7m) ($7.4m) ($113.4m) $41.7m ($13.2m) ($43.6m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $4.5m $8.0m $0 $30.0m $0 $0 $31.0m $9.4m $73.5m $25.0m
Repayments of Long-term Debt $102k $78k $113k — — — — — — —
Proceeds from Issuance of Common Stock $0 $53.8m $43.4m $60.0m $70.2m $0 $139.3m $0 $0 —
Dividends paid $0 $6.0m $0 $0 — — — — — —
Net Cash Provided by (Used in) Financing Activities $3.6m $54.7m $39.7m $91.0m $46.7m $6k $136.0m $7.3m $53.1m $24.0m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $0 $0 $8k ($404k) ($658k) $619k $633k ($175k) $348k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — $0 $0 $11.3m ($41.9m) ($21.1m) $1.5m $22.6m $12.8m ($24.2m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — $72.0m $30.1m $9.0m $10.5m $33.0m $45.8m $21.6m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.5m $2.5m $2.3m $4.2m $1.2m $56k $700k $42k $2.8m $6.5m
Income Taxes Paid, Net — — — — — — — — — $171k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.